DEVELOPMENT OF TARGETED NANOPARTICLE DRUG DELIVERY FOR SURGICAL CANCER THERAPY: EFFECTS ON PHARMACOKINETICS, TUMOR ACCUMULATION, THERAPEUTIC EFFICACY, AND SYSTEMIC TOXICITY. Biosci. Insights. 2026, 3 (02), 854-864.